Adhera Therapeutics, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Salberg & Company, P.A., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.017 USD | +143.90% |
|
+174.19% | -43.33% |
1st Jan change | Capi. | |
---|---|---|
-43.33% | 198K | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- ATRX Stock
- News Adhera Therapeutics, Inc.
- Adhera Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt